ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc.
TARS
時価総額
$11.4億
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
iso4217:USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2023年
12月31日
Cash and cash equivalents
225
Marketable securities
2
Other receivables
1
Accounts receivable, net
17
Prepaid expenses
8
Inventory
3
Total current assets
256
Other receivables
1
Prepaid expenses
8
Total current assets
256
Property and equipment, net
1
Operating lease right-of-use assets
2
Intangible assets, net
4
Long-term investments
1
Operating lease right-of-use assets
2
Other assets
2
Long-term investments
1
Total assets
265
Other assets
2
Total assets
265
Accounts payable and other accrued liabilities
24
Accrued payroll and benefits
13
Total current liabilities
37
Term loan, net
30
Other long-term liabilities
2
Total liabilities
69
Common Stock, Value, Issued
0
Additional paid-in capital
442
Accumulated other comprehensive loss
-0
Accumulated deficit
-245
Total stockholders’ equity
197
Total liabilities and stockholders’ equity
265